Featured review: Breastfeeding or breast milk for procedural pain in newborn babies
Wednesday, August 30, 2023
Source: Cochrane News and Events - August 30, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Online self-scheduling use in mammography increases
The use of online self-scheduling for screening mammography has increased b...Read more on AuntMinnie.comRelated Reading: Can self-scheduling and referral close breast cancer screening gaps? Systemic factors linked to incomplete breast imaging follow-up Study shows many women aren't receiving mammograms Digital scheduling tools may widen breast cancer disparities How equitable is online patient scheduling for mammography?
Source: AuntMinnie.com Headlines - August 30, 2023 Category: Radiology Source Type: news

Distributing imaging services could improve reimbursement
Distributing CT and MRI services between sites for Medicare patients could improv...Read more on AuntMinnie.comRelated Reading: Proposed Medicare rule will not improve radiology reimbursement ACR: Radiology could take up to 4% reimbursement reduction in 2024 MICI 2023 Q3: Radiology administrators confident about imaging growth CMS proposes radiology reimbursement cuts, AUC pause for 2024 MPFS ACR weighs in on CMS proposed Medicare cuts
Source: AuntMinnie.com Headlines - August 30, 2023 Category: Radiology Source Type: news

U.S. Department of the Treasury, IRS Release Guidance on Inflation Reduction Act Provision to Ensure Good-Paying Clean Energy Jobs, Expand Clean Energy …
Guidance completes Phase 1 of Treasury Department Inflation Reduction Act Implementation, advances President Biden’s Investing in America agendaWASHINGTON — As part of the Biden-Harris Administration’s Investing in America agenda, the U.S. Department of the Treasury and the Internal Revenue…#phase1 #usdepartment #treasury #nprm #treasurydepartments #usdepartmentoflabor #janetlyellen #bidenharris #juliesu #bidenomics
Source: Reuters: Health - August 30, 2023 Category: Consumer Health News Source Type: news

Breast Expert Gregory M. Fedele, MD Joins Exclusive Haute Beauty Network
Gregory M. Fedele, MD joins the Haute Beauty Network as a breast expert representing the Cleveland, OH market. CLEVELAND, Aug. 30, 2023 /PRNewswire-PRWeb/ -- Gregory M. Fedele, MD is a native of the Cleveland area. He attended St. Joseph High School in Cleveland and went on to major in...
Source: PRWeb: Medical Pharmaceuticals - August 30, 2023 Category: Pharmaceuticals Tags: PER Source Type: news

J & J, Lupin cut prices for tuberculosis drug in lower-income countries
Johnson& Johnson and Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and middle-income countries, according to the Stop TB Partnership. The new prices, $130 for J&J and $194 for Lupin for a six-month course of treatment, represent a 55% and 33% reduction, respectively. Bedaquiline is a key part of recommended treatment regimens for drug-resistant TB infections, and this price reduction will help broaden access to the life-saving drug.
Source: The Economic Times Healthcare and Biotech News - August 30, 2023 Category: Pharmaceuticals Source Type: news

Gender-affirming Surgeries Way Up Between 2016 and 2019 Gender-affirming Surgeries Way Up Between 2016 and 2019
Breast and chest surgeries were the most common procedures, a study found.Medscape Medical News
Source: Medscape Medical News Headlines - August 29, 2023 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

More women under 40 are being diagnosed with breast cancer. What to know about the potential reasons and risks
While the median age for getting diagnosed with breast cancer is 62, research shows more young women are facing grim results—many of whom are experiencing more aggressive forms of the cancer. Breast cancer—the most common cancer for women—makes up a third of new cancer diagnoses in women each…#beverlymoy #jamanetwork #aya #amycomander #fortunecom #fortune
Source: Reuters: Health - August 29, 2023 Category: Consumer Health News Source Type: news

Combined AI, Mammography Texture Model Improves Breast CA Risk Prediction
TUESDAY, Aug. 29, 2023 -- Combining artificial intelligence (AI) with mammography texture models improves breast cancer risk assessment, according to a study published online Aug. 29 in Radiology. Andreas D. Lauritzen, Ph.D., from the University of...
Source: Drugs.com - Pharma News - August 29, 2023 Category: Pharmaceuticals Source Type: news

CEUS with perfluorobutane improves HCC diagnosis
Contrast-enhanced ultrasound (CEUS) with Kupffer-cell agents has high specificit...Read more on AuntMinnie.comRelated Reading: CEUS improves O-RADS diagnostic performance Multimodality ultrasound risk model outperforms TI-RADS ABUS, CEUS could help predict breast cancer treatment response CEUS can rule out small bowel ischemia Modified CEUS method does well in categorizing liver lesions
Source: AuntMinnie.com Headlines - August 29, 2023 Category: Radiology Source Type: news

Biden Administration Unveils First Drugs for Medicare Price Negotiations
The price negotiation program, established by Democrats as part of the Inflation Reduction Act, is expected to save the government tens of billions of dollars in the coming years.
Source: NYT - August 29, 2023 Category: American Health Authors: Sheryl Gay Stolberg and Rebecca Robbins Tags: Drugs (Pharmaceuticals) Prices (Fares, Fees and Rates) Medicare Health Insurance and Managed Care Inflation Reduction Act of 2022 Biden, Joseph R Jr United States Politics and Government Democratic Party Source Type: news

Thousands of cancer patients in England to be first in world to receive revolutionary seven-minute jab instead of an hour-long transfusion
The NHS said up to 3,600 people a year in England with specific types of lung, bladder, breast or liver cancer are set to benefit from the change.
Source: the Mail online | Health - August 29, 2023 Category: Consumer Health News Source Type: news

Roche ’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenousTecentriq, including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatmentAdministered under the skin within approx. seven minutes,Tecentriq SC saves time for patients and helps conserve resources in healthcare systems1Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Tecentriq ® SC (atezolizumab) has been approved by the Medicines and Healthcare products Reg...
Source: Roche Investor Update - August 29, 2023 Category: Pharmaceuticals Source Type: news

ESC: Semaglutide Beneficial for HFpEF Patients With Obesity
TUESDAY, Aug. 29, 2023 -- For patients with heart failure with preserved ejection fraction and obesity, semaglutide is associated with a larger reduction in symptoms and physical limitations, according to a study published online Aug. 25 in the New...
Source: Drugs.com - Pharma News - August 29, 2023 Category: Pharmaceuticals Source Type: news

Roche ’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenousTecentriq, including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatmentAdministered under the skin within approx. seven minutes,Tecentriq SC saves time for patients and helps conserve resources in healthcare systems1Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Tecentriq ® SC (atezolizumab) has been approved by the Medicines and Healthcare products Reg...
Source: Roche Media News - August 29, 2023 Category: Pharmaceuticals Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20